Aktis Oncology Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Aktis Oncology Inc
Aktis Oncology Inc is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. The company specializes in developing targeted alpha radiopharmaceuticals for solid tumors such as breast, lung, colorectal, bladder, and liver cancers. Its pipeline products include AKY-1189 and AKY-2519, focusing on solid tumors. It has one operating segment focused on the research and development of targeted radiopharmaceuticals.
/ 
Others were interested in
Frequently asked questions
To buy Aktis Oncology Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Aktis Oncology Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Aktis Oncology Inc is AKTS:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Aktis Oncology Inc has its primary listing on NASDAQ. You can trade Aktis Oncology Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Aktis Oncology Inc is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Aktis Oncology Inc as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Aktis Oncology Inc.